Tempe, AZ, February 22, 2018 – SDC, a specialized data services Contract Research Organization (CRO) providing scalable clinical trial services, is excited to announce a new key initiative: the establishment of a Strategic Scientific Consulting group. This initiative will support continued efforts to broaden the range of strategic-level support that SDC provides to clients and partners throughout the lifespan of their clinical development programs. This offering will not only provide access to SDC’s internal world-class statistical and scientific expertise, but will also leverage SDC’s ever-growing network of medical and regulatory key opinion leaders to deliver best-in-class strategic consulting services to pharmaceutical, biotechnology, and medical device companies.
Dale W. Usner, Ph.D., will be spearheading this key initiative as Chief Scientific Officer (CSO) & Senior Vice President (SVP), Strategic Scientific Consulting. He brings to this role over 20 years of extensive experience across multiple therapeutic areas, and has played an instrumental role in support of more than 20 product approvals. Throughout his 6 years at SDC, Dr. Usner has proven himself as both a strong leader and a deep technical expert.
“SDC’s clients have come to trust the thought leadership and strategic guidance that our team has provided for many years,” said Dr. Usner. “The formalization of our Strategic Scientific Consulting group further enables SDC to better serve our clients in their clinical program development strategy.”
Through this continually expanding network of strategic experts, SDC will provide a full range of protocol and program development services. Internally, this group will also serve to develop and mentor aspiring team members on protocol and program development, and continue to define SDC as a thought leader on new statistical techniques and regulatory guidance changes.
“Dale’s passionate, hands-on approach – and his strategic perspective that has gained the continued trust of SDC’s clients – has been key in helping the success of many pharma, biologic, and medical device programs,” said Richard Abelson, Ph.D., President & CEO at SDC. “Under Dale’s leadership, I am confident that SDC’s Strategic Scientific Consulting group will help many clients advance their therapies through clinical development and bring new and better treatments to patients around the world.”
SDC is committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects. SDC delivers leading-edge statistical analysis and data management services to pharmaceutical, biotechnology, and medical device companies, as well as CRO partners. With biostatistics, clinical data management/EDC, and interactive response technology (IRT) expertise at our core, SDC also provides scalable full service clinical trial solutions via our diverse and complementary strategic partnerships. Speak with us today about how SDC will take ownership of your clinical project needs. For more information, please visit www.sdcclinical.com, call 480-632-5468, or email firstname.lastname@example.org.